Pfizer Limited (BOM:500680)

Market Cap	221.85B +16.3%
Revenue (ttm)	24.82B +11.0%
Net Income	8.54B +38.7%
EPS	186.59 +38.7%
Shares Out	n/a
PE Ratio	25.99
Forward PE	26.34
Dividend	165.00 (3.35%)
Ex-Dividend Date	Jul 9, 2025

Volume	411
Average Volume	6,209
Open	4,806.75
Previous Close	4,859.10
Day's Range	4,771.00 - 4,899.90
52-Week Range	3,742.90 - 5,987.65
Beta	n/a
RSI	45.92
Earnings Date	Feb 9, 2026

About Pfizer

Pfizer Limited engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally. It offers its products in various therapeutic areas, including neuro/CNS, hormones, cardiovascular, haemophilia, anti-infectives, gynecology, pain/analgesics, orthopedic, oncology, urology, anti-parasitic, gastrointestinal, vaccines, and respiratory, as well as vitamins, minerals, and nutrients. The company also offers anti-infectives services to hospitals and nursing homes. It sells its products through a netwo...

• Industry: Pharmaceutical Preparations
• Founded: 1950
• Employees: 1,598
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 500680

Financial Performance

In fiscal year 2025, Pfizer's revenue was 22.81 billion, an increase of 4.02% compared to the previous year's 21.93 billion. Earnings were 7.68 billion, an increase of 39.23%.